Tag | Content |
---|
EnhancerAtlas ID | HS073-04953 |
Organism | Homo sapiens |
Tissue/cell | GM19238 |
Coordinate | chr16:1768210-1768750 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOSL1 | MA0477.1 | chr16:1768463-1768474 | CATGAGTCACC | - | 6.62 | JUND | MA0491.1 | chr16:1768463-1768474 | CATGAGTCACC | - | 6.02 | Nr2f6(var.2) | MA0728.1 | chr16:1768578-1768593 | GAGGTCAGGAGTTCA | + | 6.22 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_10840 | chr16:1768606-1770915 | CD19_Primary | SE_47423 | chr16:1768695-1771020 | Panc1 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr16 | 1768373 | 1768602 | chr16 | 1768406 | 1768499 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH16I001718 | chr16 | 1768069 | 1770665 |
|
Enhancer Sequence | GTTTCACTCT TGTCACTCGG GCTGGAGTGC AATGTCATGG CCTCGGCTCA CTGCAACCTC 60 TGCCTCCCGT GTTCAAGAGA TTCTCCTGCC TCAGCCTCCT GAGTAGCTGG GATTACAGGC 120 ATGCATCACC ATGCCTGGCT AATTTTGTAT TTTTAGTAGA GACGGGGTTT CACCAAGTTG 180 GCCAGGCTGC TCTGGAACTC CTGACCTCAG GTGATCCCCC CACCTCGGCC TCCTAAAGTG 240 CTGGGATTAC AGGCATGAGT CACCGCGCCC GGCTAATGAT CTTTAAATAA AAATATTTTC 300 TAGGCCGGGT ACGGTGGCTC TCGCCTGTAA TACCAGCACT TTGGGAACCC AAGGCAGGCA 360 GATTCCTTGA GGTCAGGAGT TCAAGAGCAG CCTGGCCAAC ATGGTGAAAC CCTGTCTCTA 420 CTAAGAATAC AAAAATTAGC CGGGCATGGT GGTGGGCACC TGTAATCCCA GCTAGTCAGA 480 GGCCGAGGCA GGAGAATCGC TTGAACCTGG GAGATGGAGG TTGCAGTGAG CCAAGATCGC 540
|